Review by Part C Independent Review Entity (IRE)
Guidance for if a Medicare Advantage (Part C) health plan makes an adverse reconsideration decision (upholds its initial adverse organization determination), the plan must automatically submit the case file and its decision for review by the Part C Independent Review Entity (IRE).
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 24, 2020
If a Medicare Advantage (Part C) health plan makes an adverse reconsideration decision (upholds its initial adverse organization determination), in whole or in part, the plan must automatically submit the case file and its decision for review by the Part C Independent Review Entity (IRE). If the plan dismisses a plan reconsideration request, the enrollee, the enrollee’s representative or non-contract provider has the right to file a request for review of the plan dismissal with the IRE.
For more information about appeals and dismissal review requests with the Part C IRE, see Section 60 of the Parts C & D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance, in the “Downloads” section below.
How to Request an IRE Review of a Plan Dismissal
An enrollee, an enrollee's representative, or a non-contract provider may request a reconsideration of a plan dismissal.
- The request must be filed with the IRE within 60 calendar days from the date of the plan dismissal decision notice.
- The request must be made in writing, which includes by fax.
- The request must be sent to the IRE, MAXIMUS, at:
Maximus
Medicare Managed Care & PACE Reconsideration Project
3750 Monroe Avenue
Suite 702
Pittsford, NY 14534-1302
Fax: 585-425-5292
Currently, MAXIMUS Federal Services is the Part C IRE. For additional information about MAXIMUS' reconsideration process, click on the MAXIMUS Federal Services link in the “Related Links” section below.
How the IRE Processes Reconsideration Requests
Once the case file or appeal is received by the IRE, the IRE must make its decision and provide written notice of its decision as quickly as the enrollee's health requires, but no later than the following timeframes:
- Expedited requests: 72 hours
- Standard Pre-service requests: 30 calendar days
- Standard Part B drug requests: 7 calendar days
- Payments requests: 60 calendar days
An extension of up to 14 calendar days is available if:
- requested by the enrollee; or
- actions are required by the QIC to address deficiencies in the reconsideration case file, with appropriate notification to the enrollee in accordance with regulations.
The QIC shall document the case file with the justification and rationale for the extension
Extensions are not permitted for Part B drug requests.
If the decision is unfavorable or partially favorable, the decision notice will contain the information needed to file a request for a hearing with an Administrative Law Judge within the Office of Medicare Hearings and Appeals (OMHA). Parties to the hearing may waive their right to the oral hearing and request that a decision be made based on the record. Use the left navigation menu on this page to link to other pages that contain detailed information about hearings with an ALJ and obtaining an on the record review by OMHA, or any other level of appeal.
Fact Sheets: Part C Reconsideration Appeals Data
These reports summarize and highlight key Part C IRE reconsideration data from January 1, 2017 to the most recently available date.
To view the Fact Sheets, click on the link in the "Downloads" section below.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.